Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Derfler

Showing results (71-80 of 101) with videos related to

Pageof 11
Sort By:
Transplantation Proceedings|February 1, 1989
Does cyclosporin A affect neurotransmitters? Studies after kidney transplantationH Kopsa, A Lapin, K Derfler, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 26, 1999
Low density lipoprotein immunoapheresis does not increase plasma lipid peroxidation products in vivoK Kostner, S Banyai, M Jansen, et al.
Kidney International|March 1, 1996
Beneficial effect of renal transplantation on cognitive brain functionL Kramer, C Madl, F Stockenhuber, et al.
Kidney International|October 1, 1991
Decreased postheparin lipolytic activity in renal transplant recipients with cyclosporin AK Derfler, M Hayde, G Heinz, et al.
The American Journal of Cardiology|February 1, 1993
Immediate normalization of profound sinus node dysfunction by aminophylline after cardiac transplantationG Heinz, C Kratochwill, P Buxbaum, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1998
Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosisM Haas, Y Godfrin, R Oberbauer, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1985
Immunological features of nonimmunogenic hyperthyroidismB Grubeck-Loebenstein, K Derfler, H Kassal, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1987
Prevention of nephrotoxic cyclosporine peak concentrations by daily drug division in 3 equal oral portionsJ Zazgornik, J Schindler, P Balcke, et al.
Wiener Klinische Wochenschrift|April 27, 1984
[Radionuclide studies in chronically hemodialyzed patients. Bone scintigraphy for the evaluation and control of renal osteopathy]R Dudczak, K Kletter, H Czembirek, et al.
Annals of Medicine|November 14, 1998
Urinary apolipoprotein (a) excretion in patients with proteinuriaK M Kostner, S Banyai, M Banyai, et al.
Pageof 11

Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Transplantation Proceedings|February 1, 1989
Does cyclosporin A affect neurotransmitters? Studies after kidney transplantationH Kopsa, A Lapin, K Derfler, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 26, 1999
Low density lipoprotein immunoapheresis does not increase plasma lipid peroxidation products in vivoK Kostner, S Banyai, M Jansen, et al.
Kidney International|March 1, 1996
Beneficial effect of renal transplantation on cognitive brain functionL Kramer, C Madl, F Stockenhuber, et al.
Kidney International|October 1, 1991
Decreased postheparin lipolytic activity in renal transplant recipients with cyclosporin AK Derfler, M Hayde, G Heinz, et al.
The American Journal of Cardiology|February 1, 1993
Immediate normalization of profound sinus node dysfunction by aminophylline after cardiac transplantationG Heinz, C Kratochwill, P Buxbaum, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1998
Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosisM Haas, Y Godfrin, R Oberbauer, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1985
Immunological features of nonimmunogenic hyperthyroidismB Grubeck-Loebenstein, K Derfler, H Kassal, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1987
Prevention of nephrotoxic cyclosporine peak concentrations by daily drug division in 3 equal oral portionsJ Zazgornik, J Schindler, P Balcke, et al.
Wiener Klinische Wochenschrift|April 27, 1984
[Radionuclide studies in chronically hemodialyzed patients. Bone scintigraphy for the evaluation and control of renal osteopathy]R Dudczak, K Kletter, H Czembirek, et al.
Annals of Medicine|November 14, 1998
Urinary apolipoprotein (a) excretion in patients with proteinuriaK M Kostner, S Banyai, M Banyai, et al.
Pageof 11